Consort Medical’s (LSE: CSRT) Bespak division has today launched a new, improved, company website. The contemporary website reflects the new Bespak structure and exciting developments within the company, including the recent founding of the Bespak Innovation Centre. Located in Cambridge, the Bespak Innovation Centre is already actively engaged in a variety of medical device innovation projects both in our current core markets of Respiratory and Injectables and additionally in new healthcare areas where our unique skill-sets are relevant.
In addition to showcasing the extensive product range from Bespak’s traditional Respiratory business, the new website integrates Bespak Injectables (formerly The Medical House; acquired by Consort Medical in 2009). Bespak Injectables’ Auto Injector devices are represented alongside Bespak Respiratory’s Valves & Actuators, Integrated Dose Counters, Medical Check Valves and Customer Inhalation Devices. This allows the new website to reflect Bespak’s strength and depth in drug delivery devices and the skills and experience it has in the management and delivery of successful device programmes.
The new-look website provides visitors to the site with a positive browsing experience and is designed to facilitate user engagement and ease-of-navigation. Visitors can easily access information on Bespak’s comprehensive range of capabilities and the scope of services offered to customers in the design and manufacturing of drug delivery devices.
By embracing social media tools and featuring News and Events pages, the new website offers interested parties the ability to follow news and developments at Bespak and connect directly with the company.
Joe Barry, Managing Director at Bespak said, “The upgraded website is a great vehicle to give our customers an introduction to the exciting products and services we offer. Now we have created Bespak Injectables, we feel this is the perfect time to give our existing and potential customers an updated overview of our expertise in the Respiratory and Injectables market which can also be translated into other market segments. I do hope you find it user friendly and informative.”
Bespak, a Consort Medical company, is a leading global supplier of drug delivery devices for injectable and inhaled products.
Bespak has contributed to the design, development and industrialisation of some of the world’s leading medical devices. Headquarted in the UK and with representation in a number of key territories, Bespak employs over 600 people and manufactures more than 500 million medical devices each year, supporting device programmes from pilot-scale to commercial supply.
Bespak’s product technologies include; MDI Valves & Actuators, Integrated Dose Counters, Inhalation Devices, Medical Check Valves, Auto Injectors and Needle-free Jet Injectors.
For more information please visit https://www.bespak.com/ or click here to contact Bespak.